A drug used to treat type 2 diabetes has been recommended for use in triple therapies for those unable to use the current method. Exenatide is currently administered once a week as a long acting medication.
This guidance suggests that for those with a BMI over 35 or patients unable to use insulin Exenatide could be used with a combination of other drugs. It could then be prescribed as a triple treatment option.
For more on this story click here
talkhealth
This is the talkhealth blog spot, where we post on a wide range of health conditions, topics, issues and concerns. We post when we see something that we believe is of interest to our visitors. Our posts do not reflect any particular view or standpoint of talkhealth, but are merely to raise attention and awareness.
Join with Google
Join with Facebook